| 2022 |
Impact of Different Selection Approaches for Identifying Lynch Syndrome-Related Colorectal Cancer Patients: Unity Is Strength |
Articolo in rivista |
Vai |
| 2022 |
BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaning |
Articolo in rivista |
Vai |
| 2022 |
Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies |
Articolo in rivista |
Vai |
| 2022 |
Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors? |
Articolo in rivista |
Vai |
| 2022 |
MUTYH-associated tumor syndrome: The other face of MAP |
Articolo in rivista |
Vai |
| 2022 |
The molecular tumor board: a tool for the governance of precision oncology in the real world |
Articolo in rivista |
Vai |
| 2022 |
Safety and effectiveness of gemcitabine for the treatment of classic Kaposi’s sarcoma without visceral involvement |
Articolo in rivista |
Vai |
| 2021 |
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma |
Articolo in rivista |
Vai |
| 2021 |
COVID-19 infection in cancer patients: what has been the contribution of Associazione Italiana Oncologia Medica (AIOM) to oncological care since the beginning of the first pandemic wave? |
Articolo in rivista |
Vai |
| 2021 |
Immune checkpoint inhibitors-associated pericardial disease: a systematic review of case reports |
Articolo in rivista |
Vai |
| 2021 |
Challenges and advances for the treatment of renal cancer patients with brain metastases: From immunological background to upcoming clinical evidence on immune-checkpoint inhibitors |
Review essay (rassegna critica) |
Vai |
| 2021 |
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial |
Articolo in rivista |
Vai |
| 2021 |
Non-Small Cell Lung Cancer Harboring Concurrent EGFR Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma |
Recensione in rivista |
Vai |
| 2021 |
Is there any place for PD-1/CTLA-4 inhibitors combination in the first-line treatment of advanced NSCLC?—A trial-level meta-analysis in PD-L1 selected subgroups |
Articolo in rivista |
Vai |
| 2021 |
Prognostic role of plasma pd‐1, pd‐l1, pan‐btn3as and btn3a1 in patients affected by metastatic gastrointestinal stromal tumors: Can immune checkpoints act as a sentinel for short‐term survival? |
Articolo in rivista |
Vai |
| 2021 |
Is there any room for PD-1 inhibitors in combination with platinum-based chemotherapy as frontline treatment of extensive-stage small cell lung cancer? A systematic review and meta-analysis with indirect comparisons among subgroups and landmark survival analyses |
Articolo in rivista |
Vai |
| 2021 |
The prognostic impact of tumor mutational burden (TMB) in the first-line management of advanced non-oncogene addicted non-small-cell lung cancer (NSCLC): a systematic review and meta-analysis of randomized controlled trials |
Articolo in rivista |
Vai |
| 2021 |
Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome |
Articolo in rivista |
Vai |
| 2021 |
POLE, POLD1, and NTHL1: the last but not the least hereditary cancer-predisposing genes |
Review essay (rassegna critica) |
Vai |
| 2021 |
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge |
Articolo in rivista |
Vai |
| 2021 |
Second medical opinion in oncological setting |
Articolo in rivista |
Vai |
| 2021 |
Type and gene location of kit mutations predict progression-free survival to first-line imatinib in gastrointestinal stromal tumors: A look into the exon |
Articolo in rivista |
Vai |
| 2021 |
Arterial Stiffness: Effects of Anticancer Drugs Used for Breast Cancer Women |
Articolo in rivista |
Vai |
| 2021 |
Role of the HIPPO pathway as potential key player in the cross talk between oncology and cardiology |
Articolo in rivista |
Vai |
| 2021 |
TargetPlex FFPE-Direct DNA Library Preparation Kit for SiRe NGS panel: An international performance evaluation study |
Articolo in rivista |
Vai |
| 2021 |
S-Adenosylmethionine Supplementation May Reduce Cancer-Related Fatigue: A Prospective Evaluation Using the FACIT-F Questionnaire in Colon Cancer Patients Undergoing Oxaliplatin-Based Chemotherapy Regimens |
Articolo in rivista |
Vai |
| 2021 |
Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance |
Articolo in rivista |
Vai |
| 2021 |
Current treatment options for HER2-positive breast cancer patients with brain metastases |
Articolo in rivista |
Vai |
| 2021 |
INfluenza Vaccine Indication during therapy with Immune checkpoint inhibitors: A multicenter prospective observational study (INVIDIa-2) |
Articolo in rivista |
Vai |
| 2021 |
The tumor-agnostic treatment for patients with solid tumors: a position paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIF Italian Scientific Societies |
Articolo in rivista |
Vai |
| 2021 |
The molecular profiling of solid tumors by liquid biopsy: a position paper of the AIOM–SIAPEC-IAP–SIBioC–SIC–SIF Italian Scientific Societies |
Articolo in rivista |
Vai |
| 2021 |
Early prediction of pancreatic cancer from new-onset diabetes: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper |
Articolo in rivista |
Vai |
| 2021 |
Antineoplastic dosing in overweight and obese cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper |
Articolo in rivista |
Vai |
| 2021 |
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting |
Articolo in rivista |
Vai |
| 2021 |
Effectiveness of a Psychosocial Care Quality Improvement Strategy to Address Quality of Life in Patients with Cancer: The HuCare2 Stepped-Wedge Cluster Randomized Trial |
Articolo in rivista |
Vai |
| 2020 |
Prognostic clinical factors in patients affected by non-small-cell lung cancer receiving Nivolumab |
Articolo in rivista |
Vai |
| 2020 |
Irinotecan or oxaliplatin: Which is the first move for the mate? |
Articolo in rivista |
Vai |
| 2020 |
CARDIOVASCULAR RISK IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA: THROMBOTIC RISK AND SURVIVAL |
Articolo in rivista |
Vai |
| 2020 |
The Essential Thrombocythemia, Thrombotic Risk Stratification, and Cardiovascular Risk Factors |
Articolo in rivista |
Vai |
| 2020 |
The significance of epidermal growth factor receptor uncommon mutations in non-small cell lung cancer: A systematic review and critical appraisal |
Articolo in rivista |
Vai |
| 2020 |
2020 Reply to: Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials |
Lettera |
Vai |
| 2020 |
KRAS mutations testing in non-small cell lung cancer: The role of Liquid biopsy in the basal setting |
Articolo in rivista |
Vai |
| 2020 |
COVID-19 Infection in Cancer Patients: How Can Oncologists Deal With These Patients? |
Articolo in rivista |
Vai |
| 2020 |
Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score |
Articolo in rivista |
Vai |
| 2020 |
Management of metabolic adverse events of targeted therapies and immune checkpoint inhibitors in cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper |
Articolo in rivista |
Vai |
| 2020 |
Fatal heart failure induced by pazopanib in a sarcoma patient previously treated with gemcitabine |
Articolo in rivista |
Vai |
| 2020 |
Cardiovascular Toxicity in Cancer Patients Treated with Tyrosine Kinase Inhibitors: A Real-World Single-Center Experience |
Articolo in rivista |
Vai |
| 2020 |
Cardiovascular risk in polycythemia vera: Thrombotic risk and survival: Can cytoreductive therapy be useful in patients with low-risk polycythemia vera with cardiovascular risk factors? |
Articolo in rivista |
Vai |
| 2020 |
Hereditary breast and ovarian cancer in families from southern Italy (Sicily)—Prevalence and geographic distribution of pathogenic variants in BRCA1/2 genes |
Articolo in rivista |
Vai |
| 2020 |
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2 |
Articolo in rivista |
Vai |
| 2020 |
Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions |
Articolo in rivista |
Vai |
| 2020 |
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study |
Articolo in rivista |
Vai |
| 2020 |
Impact of BMI on Preoperative Axillary Ultrasound Assessment in Patients With Early Breast Cancer |
Articolo in rivista |
Vai |
| 2020 |
Tumor mutational burden on cytological samples: A pilot study |
Articolo in rivista |
Vai |
| 2020 |
A “lymphocyte microrna signature” as predictive biomarker of immunotherapy response and plasma pd-1/pd-l1 expression levels in patients with metastatic renal cell carcinoma: Pointing towards epigenetic reprogramming |
Articolo in rivista |
Vai |
| 2020 |
BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients |
Articolo in rivista |
Vai |
| 2020 |
The emerging therapeutic landscape of alk inhibitors in non-small cell lung cancer |
Review essay (rassegna critica) |
Vai |
| 2020 |
Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study |
Articolo in rivista |
Vai |
| 2019 |
Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone? |
Review essay (rassegna critica) |
Vai |
| 2019 |
Reccomendations for using of molecular assays on liquid biopsy: The first document provided by intersociety Group AIOM, SIF, SIAPEC-IAP, SIBioC |
Articolo in rivista |
Vai |
| 2019 |
Prognostic significance of circulating PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTLA in patients with pancreatic adenocarcinoma |
Articolo in rivista |
Vai |
| 2019 |
Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients |
Articolo in rivista |
Vai |
| 2019 |
Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system |
Articolo in rivista |
Vai |
| 2019 |
One shot NEPA plus dexamethasone to prevent multiple-day chemotherapy in sarcoma patients |
Articolo in rivista |
Vai |
| 2019 |
Immunomodulation in vascularized composite allotransplantation: What is the role for adipose-derived stem cells? |
Articolo in rivista |
Vai |
| 2019 |
Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: an update from clinical practice |
Articolo in rivista |
Vai |
| 2019 |
An update on the conquests and perspectives of cardio-oncology in the field of tumor angiogenesistargeting TKI-based therapy |
Articolo in rivista |
Vai |
| 2019 |
How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis |
Articolo in rivista |
Vai |
| 2019 |
Epidermal Growth Factor Receptor (EGFR) Cell Expression During Adjuvant Treatment After Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A New Potential Tool to Identify Patients at Higher Risk of Disease Progression |
Articolo in rivista |
Vai |
| 2019 |
Comparison between thrombotic risk scores in Essential Thrombocythemia and survival implications |
Articolo in rivista |
Vai |
| 2019 |
Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in metastatic melanoma patients? |
Abstract in atti di convegno pubblicato in rivista |
Vai |
| 2019 |
Longevity: Lesson from model organisms |
Articolo in rivista |
Vai |
| 2019 |
Mitochondrion at the Crossroad Between Nutrients and Epigenome. |
Articolo in rivista |
Vai |
| 2019 |
An integrated care pathway for cancer patients with diabetes: A proposal from the Italian experience |
Articolo in rivista |
Vai |
| 2019 |
Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in patients with metastatic melanoma? |
Articolo in rivista |
Vai |
| 2019 |
Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials |
Articolo in rivista |
Vai |
| 2019 |
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients |
Articolo in rivista |
Vai |
| 2019 |
Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy |
Articolo in rivista |
Vai |
| 2019 |
Detection of RAS mutations in circulating tumor DNA: a new weapon in an old war against colorectal cancer. A systematic review of literature and meta-analysis |
Articolo in rivista |
Vai |
| 2019 |
MESENCHYMAL STEM CELLS IN PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS: IDLE OBSERVERS OR PART OF THE DISEASE? |
Abstract in atti di convegno pubblicato in rivista |
Vai |
| 2019 |
Management of Ponatinib in Patients with Chronic Myeloid Leukemia with Cardiovascular Risk Factors |
Articolo in rivista |
Vai |
| 2019 |
Are Long Noncoding RNAs New Potential Biomarkers in Gastrointestinal Stromal Tumors (GISTs)? The Role of H19 and MALAT1 |
Articolo in rivista |
Vai |
| 2019 |
How do skeletal morbidity rate and special toxicities affect 12-week versus 4-week schedule zoledronic acid efficacy? A systematic review and a meta-analysis of randomized trials |
Articolo in rivista |
Vai |
| 2019 |
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) |
Review essay (rassegna critica) |
Vai |
| 2019 |
Splenomegaly impacts prognosis in essential thrombocythemia and polycythemia vera: A single center study |
Articolo in rivista |
Vai |
| 2019 |
Correction to: One shot NEPA plus dexamethasone to prevent chemotherapy-induced nausea and vomiting (CINV) in sarcoma patients receiving multiple-day chemotherapy (Supportive Care in Cancer, (2019), 27, 9, (3593-3597), 10.1007/s00520-019-4645-3) |
Nota o commento |
Vai |
| 2019 |
Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives |
Articolo in rivista |
Vai |
| 2019 |
Insight into genetic susceptibility to male breast cancer by multigene panel testing: Results from a multicenter study in Italy |
Abstract in rivista |
Vai |
| 2018 |
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis |
Articolo in rivista |
Vai |
| 2018 |
Indications for locoregional tumor therapies: CRC liver metastases |
Capitolo o Saggio |
Vai |
| 2018 |
Looking for the best immune-checkpoint inhibitor in pre-treated NSCLC patients: An indirect comparison between nivolumab, pembrolizumab and atezolizumab |
Articolo in rivista |
Vai |
| 2018 |
Primary and metastatic brain cancer genomics and emerging biomarkers for immunomodulatory cancer treatment |
Articolo in rivista |
Vai |
| 2018 |
Spheroids from adipose-derived stem cells exhibit an miRNA profile of highly undifferentiated cells |
Articolo in rivista |
Vai |
| 2018 |
The use of same in chemotherapy-induced liver injury |
Articolo in rivista |
Vai |
| 2018 |
Immune-checkpoint inhibitors in non-small cell lung cancer: A tool to improve patients’ selection |
Articolo in rivista |
Vai |
| 2018 |
Dose-finding study of intensive weekly alternating schedule of docetaxel, 5-fluorouracil, and oxaliplatin, FD/FOx regimen, in metastatic gastric cancer |
Articolo in rivista |
Vai |
| 2018 |
Molecular profiling of pancreatic neuroendocrine tumors (pNETS) and the clinical potential |
Articolo in rivista |
Vai |
| 2018 |
Dose-finding study of oxaliplatin associated to capecitabinebased preoperative chemoradiotherapy in locally advanced rectal cancer |
Articolo in rivista |
Vai |
| 2018 |
A single-institution retrospective analysis of metachronous and synchronous metastatic bronchial neuroendocrine tumors |
Articolo in rivista |
Vai |
| 2018 |
Circular RNA in Exosomes |
Capitolo o Saggio |
Vai |
| 2018 |
The Era of PARP inhibitors in ovarian cancer: “Class Action” or not? A systematic review and meta-analysis |
Articolo in rivista |
Vai |
| 2018 |
Cardiotoxicity mechanisms of the combination of BRAF-inhibitors and MEK-inhibitors |
Articolo in rivista |
Vai |
| 2018 |
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience |
Articolo in rivista |
Vai |
| 2018 |
Adipose tissue, angiogenesis and angio-MIR under physiological and pathological conditions |
Articolo in rivista |
Vai |
| 2018 |
The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis |
Articolo in rivista |
Vai |
| 2018 |
Monoclonal antibodies for the treatment of non-hematological tumors: a safety review |
Articolo in rivista |
Vai |
| 2018 |
Real life triplet FIr/FOx chemotherapy in first-line metastatic pancreatic ductal adenocarcinoma patients: Recommended schedule for expected activity and safety and phase II study |
Articolo in rivista |
Vai |
| 2018 |
Contribution of MUtYH variants to Male breast cancer risk: Results from a multicenter study in Italy |
Articolo in rivista |
Vai |
| 2018 |
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: Final results of the phase III randomized Short-HER study |
Articolo in rivista |
Vai |
| 2018 |
A possible role of FANCM mutations in male breast cancer susceptibility: Results from a multicenter study in Italy |
Articolo in rivista |
Vai |
| 2018 |
Erratum to: The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis (Scientific Reports, (2018), 8, 1, (13379), 10.1038/s41598-018-30780-4) |
Nota o commento |
Vai |
| 2018 |
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial |
Articolo in rivista |
Vai |
| 2017 |
EGFR inhibition in NSCLC: New findings…. and opened questions? |
Articolo in rivista |
Vai |
| 2017 |
Retrospective analysis of the therapeutic efficacy of platinum/etoposide schedules in the treatment of advanced poor differentiated neuroendocrine carcinomas of the lung |
Abstract in rivista |
Vai |
| 2017 |
"Back to a false normality": New intriguing mechanisms of resistance to PARP inhibitors |
Articolo in rivista |
Vai |
| 2017 |
Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene |
Articolo in rivista |
Vai |
| 2017 |
COMPARISON OF CLINICAL AND LABORATORY DATA, INCLUDING JAK-2 46/1 HAPLOTYPE, BETWEEN PATIENTS WITH IDIOPATHIC ERYTHROCYTOSIS AND POLYCYTHEMIA VERA. |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2017 |
Liquid Biopsy in Gynecological Cancers |
Capitolo o Saggio |
Vai |
| 2017 |
Liquid Biopsy in Breast Cancer |
Capitolo o Saggio |
Vai |
| 2017 |
Circulating tumor DNA (ctDNA) as predictive biomarker in NSCLC patients treated with Nivolumab |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2017 |
Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer |
Articolo in rivista |
Vai |
| 2017 |
Olaratumab: PDGFR-α inhibition as a novel tool in the treatment of advanced soft tissue sarcomas |
Articolo in rivista |
Vai |
| 2017 |
Technical Aspects for the Evaluation of Circulating Nucleic Acids (CNAs): Circulating Tumor DNA (ctDNA) and Circulating MicroRNAs |
Capitolo o Saggio |
Vai |
| 2017 |
Risk Perception and Psychological Distress in Genetic Counselling for Hereditary Breast and/or Ovarian Cancer |
Articolo in rivista |
Vai |
| 2017 |
Molecular analysis of Spheroids from Adipose-derived Stem Cells (S-ASCs) during in vitro long-term culture. |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2017 |
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions |
Articolo in rivista |
Vai |
| 2017 |
Analysis of miRNA expression profile induced by short term starvation in breast cancer cells treated with doxorubicin |
Articolo in rivista |
Vai |
| 2017 |
Corrigendum: Cetuximab rechallenge in metastatic colorectal cancer patients: How to come away from acquired resistance? |
Articolo in rivista |
Vai |
| 2017 |
Effects of Dietary Restriction on Cancer Development and Progression |
Capitolo o Saggio |
Vai |
| 2017 |
Biochemical and chemical characterization of Cynara cardunculus L. extract and its potential use as co-adjuvant therapy of chronic myeloid leukemia |
Articolo in rivista |
Vai |
| 2017 |
Targeting angiogenesis in biliary tract cancers: An open option |
Articolo in rivista |
Vai |
| 2017 |
Exosomes as diagnostic and predictive biomarkers in lung cancer |
Articolo in rivista |
Vai |
| 2017 |
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: A real-world experience |
Articolo in rivista |
Vai |
| 2017 |
Shaking The Ground You Walk On: Are Adipose-derived Stem Cells (ASCs) True Stem Cells? |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2017 |
Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice |
Articolo in rivista |
Vai |
| 2017 |
Liquid Biopsy in Gastrointestinal Stromal Tumor |
Capitolo o Saggio |
Vai |
| 2017 |
LOWER RESPONSE TO INTRAVESICAL ADJUVANT THERAPY IN HIGH-RISK BLADDER CANCER COULD BE RELATED TO THE UROTHELIAL EXPRESSION OF EGFR |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2017 |
The activity of intravesical hyaluronic acid and chondroitin sulfate administration on urothelial gene expression. Preliminary results on the epidermal growth factor receptor and fibronectin gene expression evaluated in bladder washings of patients affected by non muscle-invasive bladder cancer |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2017 |
EGFR CELL EXPRESSION IN BLADDER WASHINGS AS A RISK MARKER TOOL IN NON MUSCLE-INVASIVE BLADDER CANCER. PRELIMINARY EXPERIENCE |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2017 |
Clinical parameters to guide decision-making in elderly metastatic colorectal CANCER patients treated with intensive cytotoxic and anti-angiogenic therapy |
Articolo in rivista |
Vai |
| 2017 |
The effects of enzalutamide and abiraterone on skeletal related events and bone radiological progression free survival in castration resistant prostate cancer patients: An indirect comparison of randomized controlled trials |
Articolo in rivista |
Vai |
| 2017 |
E26The effects of LIPUS on ctDNA release in the medium of NSCLC cell lines |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2017 |
Liquid Biopsy in Non-Small Cell Lung Cancer (NSCLC) |
Capitolo o Saggio |
Vai |
| 2017 |
Impact of phospho-Akt expression on the clinical outcome and activity of gemcitabine and Akt inhibitors in pancreatic ductal adenocarcinoma |
Abstract in atti di convegno pubblicato in rivista |
Vai |
| 2017 |
Potential miRNAs involved in molecular pathways mediating the anticancer effects of short term starvation in breast cancer cells treated with doxorubicin |
Abstract in atti di convegno pubblicato in rivista |
Vai |
| 2017 |
Baseline absolute neutrophil count (ANC), derived neutrophil-to-lymphocyte ratio (dNLR) and platelet-to-lymphocyte ratio (PLR) and outcome in non small cell lung cancer (NSCLC) treated with nivolumab or docetaxel: a preliminary analysis |
Articolo in rivista |
Vai |
| 2017 |
Safety and efficacy of the treatment with Nab-paclitaxel in mEtastatic bREast cancer In elDerly patiEnts: NEREIDE study |
Abstract in rivista |
Vai |
| 2017 |
Clinical history of thrombosis before diagnosis of overt myeloproliferative neoplasms in triple negative patients |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2016 |
FEASIBILITY OF EGFR EVALUATION IN BLADDER WASHINGS OF PATIENTS AFFECTED BY NON MUSCLE-INVASIVE BLADDER CANCER. |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2016 |
Erratum: Natural History of Non-Small-Cell Lung Cancer with Bone Metastases (Scientific Reports (2015) 5 (18670) DOI: 10.1038/srep18670) |
Nota o commento |
Vai |
| 2016 |
Absence of germline CDKN2A mutation in Sicilian Patients with Familial Malignant Melanoma: could it be a population-specific genetic signature? |
Articolo in rivista |
Vai |
| 2016 |
Chemotherapy cardiotoxicity: cardioprotective drugs and early identification of cardiac dysfunction. |
Articolo in rivista |
Vai |
| 2016 |
A headlight on liquid biopsies: a challenging tool for breast cancer management |
Articolo in rivista |
Vai |
| 2016 |
Dietary restriction: could it be considered as speed bump on tumor progression road? |
Articolo in rivista |
Vai |
| 2016 |
Beyond evidence-based data: Scientific rationale and tumor behavior to drive sequential and personalized therapeutic strategies for the treatment of metastatic renal cell carcinoma |
Articolo in rivista |
Vai |
| 2016 |
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway |
Review essay (rassegna critica) |
Vai |
| 2016 |
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis |
Articolo in rivista |
Vai |
| 2016 |
Relationship between anxiety level and radiological investigation. Comparison among different diagnostic imaging exams in a prospective single-center study |
Articolo in rivista |
Vai |
| 2016 |
HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma |
Articolo in rivista |
Vai |
| 2016 |
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus |
Articolo in rivista |
Vai |
| 2016 |
Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysis |
Articolo in rivista |
Vai |
| 2016 |
Nintedanib in NSCLC: Evidence to date and place in therapy |
Articolo in rivista |
Vai |
| 2016 |
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer? |
Articolo in rivista |
Vai |
| 2016 |
The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR status |
Articolo in rivista |
Vai |
| 2016 |
Anticancer therapy-induced vascular toxicity: VEGF inhibition and beyond |
Articolo in rivista |
Vai |
| 2016 |
The role of microRNAs in driving EGFR-TKI resistance in NSCLC cell lines |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2016 |
Non-coding RNAs functioning in colorectal cancer stem cells |
Capitolo o Saggio |
Vai |
| 2016 |
Involvement of non-coding RNAs in chemo- and radioresistance of colorectal cancer |
Capitolo o Saggio |
Vai |
| 2016 |
CALR MUTATIONS IN SICILIAN ESSENTIAL THROMBOCYTHEMIA AND MYELOFIBROSIS PATIENTS. |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2016 |
The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet? |
Articolo in rivista |
Vai |
| 2016 |
Multisciplinary management of patients with liver metastasis from colorectal cancer |
Articolo in rivista |
Vai |
| 2016 |
Cardiotoxic Effects of Anti-VEGFR Tyrosine Kinase Inhibitors |
Capitolo o Saggio |
Vai |
| 2016 |
Recommendations for the implementation of BRCA testing in the care and treatment pathways of ovarian cancer patients |
Articolo in rivista |
Vai |
| 2016 |
Central nervous system involvement in ALK-rearranged NSCLC: promising strategies to overcome crizotinib resistance |
Articolo in rivista |
Vai |
| 2016 |
Anti-angiogenic drugs for second-line treatment of NSCLC patients: Just new pawns on the chessboard? |
Articolo in rivista |
Vai |
| 2016 |
Adding chemotherapy to TKI: Can we improve first-line treatment for EGFR-mutated NSCLC patients? |
Articolo in rivista |
Vai |
| 2016 |
Male breast cancer in BRCA1 and BRCA2 mutation carriers: Pathology data from the Consortium of Investigators of Modifiers of BRCA1/2 |
Articolo in rivista |
Vai |
| 2016 |
Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin |
Articolo in rivista |
Vai |
| 2016 |
The potential of neurotrophic tyrosine kinase (NTRK) inhibitors for treating lung cancer |
Articolo in rivista |
Vai |
| 2015 |
CORRELATION BETWEEN FIBRONECTIN GENE EXPRESSION AND LOCAL TOXICITY INDUCED BY ADJUVANT INTRAVESICAL THERAPY |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2015 |
Corrigendum to "Liquid biopsies in lung cancer: The new ambrosia of researchers" [Biochem. Biophys. Act. 1846(2014) 539-546] |
Nota o commento |
Vai |
| 2015 |
Prognostic and predictive biomarkers for targeted therapy in NSCLC: For whom the bell tolls? |
Articolo in rivista |
Vai |
| 2015 |
Into the wild of long non-coding RNA in gastrointestinal stromal tumors (GISTs) to explore new prognostic/predictive biomarkers |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2015 |
What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis |
Articolo in rivista |
Vai |
| 2015 |
What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment |
Articolo in rivista |
Vai |
| 2015 |
Farletuzumab for NSCLC: Exploiting a well-known metabolic pathway for a new therapeutic strategy |
Articolo in rivista |
Vai |
| 2015 |
Natural History of Non-Small-Cell Lung Cancer with Bone Metastases |
Articolo in rivista |
Vai |
| 2015 |
Imatinib dose escalation versus sunitinib as a second line treatment in KIT exon 11 mutated GIST: a retrospective analysis |
Articolo in rivista |
Vai |
| 2015 |
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS? |
Articolo in rivista |
Vai |
| 2015 |
Bone metastases in patients with metastatic renal cell carcinoma: Are they always associated with poor prognosis? |
Articolo in rivista |
Vai |
| 2015 |
THE ROLE OF INTRAVESICAL GLYCOSAMINOGLYCANS IN TOXICITY INDUCED BY ADJUVANT INTRAVESICAL THERAPY: GENETIC LABORATORY EVIDENCE |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2015 |
UROTHELIAL EGF-R GENE EXPRESSION IN BLADDER WASHINGS: A FEASIBILITY STUDY |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2015 |
VISCERAL FAT TISSUE ACTIVITY DOES NOT CORRELATE TO HIGH GRADE PROSTATE CANCER RISK AT BIOPSY |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2015 |
Monoclonal antibodies for the treatment of non-haematological tumours: Update of an expanding scenario |
Articolo in rivista |
Vai |
| 2015 |
Prognostic relevance of objective response according to EASL criteria and mRECIST criteria in hepatocellular carcinoma patients treated with loco-regional therapies: A literature-based meta-analysis |
Articolo in rivista |
Vai |
| 2015 |
Adjuvant Chemoradiation Therapy in Gastric Cancer: Critically Reviewing the Past and Visualizing the Next Step Forward |
Articolo in rivista |
Vai |
| 2015 |
The prevalent KRAS exon 2 c.35 G>A mutation in metastatic colorectal cancer patients: A biomarker of worse prognosis and potential benefit of bevacizumab-containing intensive regimens? |
Articolo in rivista |
Vai |
| 2015 |
The changes of lipid metabolism in advanced renal cell carcinoma patients treated with everolimus: A new pharmacodynamic marker? |
Articolo in rivista |
Vai |
| 2015 |
Entrectinib: A potent new TRK, ROS1, and ALK inhibitor |
Articolo in rivista |
Vai |
| 2015 |
Hepatocellular carcinoma treatment over sorafenib: Epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel? |
Articolo in rivista |
Vai |
| 2015 |
Novel and known genetic variants for male breast cancer risk at 8q24.21, 9p21.3, 11q13.3 and 14q24.1: Results from a multicenter study in Italy |
Articolo in rivista |
Vai |
| 2015 |
Cancer and the microbiome: Potential applications as new tumor biomarker |
Articolo in rivista |
Vai |
| 2015 |
Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy |
Review essay (rassegna critica) |
Vai |
| 2015 |
Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients |
Articolo in rivista |
Vai |
| 2015 |
Micro-RNA in pancreatic adenocarcinoma: Predictive/prognostic biomarkers or therapeutic targets? |
Articolo in rivista |
Vai |
| 2015 |
Use of the word “cured” for cancer patients—implications for patients and physicians: The Siracusa charter |
Abstract in rivista |
Vai |
| 2015 |
VIPoma and PPoma |
Capitolo o Saggio |
Vai |
| 2015 |
Deregulation of dicer and mir-155 expression in liposarcoma |
Articolo in rivista |
Vai |
| 2015 |
Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial |
Articolo in rivista |
Vai |
| 2015 |
Alla ricerca della sicurezza e della qualità: il modello di miglioramento dell’Oncologia nel Policlinico Universitario di Palermo |
Articolo in rivista |
Vai |
| 2014 |
FIBRONECTIN (FN) AND UROTHELIAL
DAMAGE SECONDARY TO ADJUVANT
INTRAVESICAL THERAPY |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2014 |
Natural history of malignant bone disease in hepatocellular carcinoma: final results of a multicenter bone metastasis survey |
Articolo in rivista |
Vai |
| 2014 |
Well-being among Italian medical oncologists: An exploratory study |
Articolo in rivista |
Vai |
| 2014 |
Targeted Therapies in Hepatocellular Carcinoma |
Articolo in rivista |
Vai |
| 2014 |
Immunotherapy for recurrent ovarian cancer: a further piece of the puzzle or a striking strategy? |
Articolo in rivista |
Vai |
| 2014 |
Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung Cancer |
Articolo in rivista |
Vai |
| 2014 |
Immunotherapy: is a minor god yet in the pantheon of treatments for lung cancer? |
Articolo in rivista |
Vai |
| 2014 |
Evaluation of anxiety level in patients wating to undergo to diagnostic radiological exams |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2014 |
Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitors |
Articolo in rivista |
Vai |
| 2014 |
Looking for a new panacea in ALK-rearranged NSCLC: may be Ceritinib? |
Articolo in rivista |
Vai |
| 2014 |
Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects |
Articolo in rivista |
Vai |
| 2014 |
How to find the Ariadne's thread in the labyrinth of salvage treatment options for metastatic colorectal cancer? |
Articolo in rivista |
Vai |
| 2014 |
Utility of laser microdissection and pressure catapulting in the diagnosis of non small cell lung cancer: preliminary data. |
Articolo in rivista |
Vai |
| 2014 |
Molecular target therapy for bone metastasis: starting a new era with denosumab, a RANKL inhibitor |
Articolo in rivista |
Vai |
| 2014 |
Circulating miR-22, miR-24 and miR-34a as Novel Predictive Biomarkers to Pemetrexed-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer |
Articolo in rivista |
Vai |
| 2014 |
Exosomal shuttling of miR-126 in endothelial cells modulates adhesive and migratory abilities of chronic myelogenous leukemia cells |
Articolo in rivista |
Vai |
| 2014 |
Liquid biopsies in lung cancer: The new ambrosia of researchers |
Articolo in rivista |
Vai |
| 2014 |
Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility? |
Articolo in rivista |
Vai |
| 2014 |
Ramucirumab and its use in gastric cancer treatment |
Articolo in rivista |
Vai |
| 2014 |
ALK and crizotinib: After the honeymoon...what else? Resistance mechanisms and new therapies to overcome it |
Articolo in rivista |
Vai |
| 2014 |
The role of cMET in non-small cell lung cancer resistant to EGFR-Inhibitors: Did we really find the target? |
Articolo in rivista |
Vai |
| 2014 |
Estimated glomerular filtration rate is an easy predictor of venous thromboembolism in cancer patients undergoing platinum-based chemotherapy |
Articolo in rivista |
Vai |
| 2014 |
Association of SULT1A1 Arg213His polymorphism with male breast cancer risk: results from a multicenter study in Italy |
Articolo in rivista |
Vai |
| 2014 |
Fibronectin (FN), epidermal growth factor-receptor (EGF-R) and heparin-binding epidermal growth factor-like
(HB-EGF) urinary expressions and topical toxicity of adjuvant intravesical therapy for non muscle invasive
bladder cancer (NMI-BC) |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2014 |
Pharmacogenomics of cetuximab in metastatic colorectal carcinoma |
Articolo in rivista |
Vai |
| 2014 |
The role of targeted therapy for gastrointestinal tumors |
Articolo in rivista |
Vai |
| 2013 |
The molecular changes driving the carcinogenesis in Barrett's esophagus: Which came first, the chicken or the egg? |
Articolo in rivista |
Vai |
| 2013 |
Management of Toxicity Induced by Anti-EGFR Therapy
in Metastatic Colorectal Cancer |
Articolo in rivista |
Vai |
| 2013 |
Natural history of malignant bone disease in renal cancer: final results of an Italian bone metastasis survey. |
Articolo in rivista |
Vai |
| 2013 |
Novel insulin receptor substrate 1 and 2 variants in breast and colorectal cancer |
Articolo in rivista |
Vai |
| 2013 |
Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense? |
Articolo in rivista |
Vai |
| 2013 |
Studio pilota sul valore predittivo dei livelli plasmatici di 9 fattori angiogenetici nella selezione di pazienti candidati alla biopsia prostatica |
Articolo in rivista |
Vai |
| 2013 |
Association of low-penetrance alleles with male breast cancer risk and clinicopathological characteristics: results from a multicenter study in Italy |
Articolo in rivista |
Vai |
| 2013 |
Analysis of Germline Gene Copy Number Variants of Patients with Sporadic Pancreatic Adenocarcinoma Reveals Specific Variations |
Articolo in rivista |
Vai |
| 2013 |
Monoclonal antibodies in gastrointestinal cancers |
Articolo in rivista |
Vai |
| 2013 |
Fibronectin (FN), Epidermal Growth Factor-Receptor (EGF-R) and Heparin-Binding Epidermal Growth Factor-Like Growth Factor (HB-EGF) expressions in relation to toxicity of adjuvant intravesical therapy for non-muscle invasive bladder cancer. |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2013 |
The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients |
Articolo in rivista |
Vai |
| 2013 |
Natural History of Malignant Bone Disease in Gastric Cancer: Final Results of a Multicenter Bone Metastasis Survey |
Articolo in rivista |
Vai |
| 2013 |
Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness. |
Articolo in rivista |
Vai |
| 2013 |
High density of tryptase-positive mast cells in human colorectal cancer: a poor prognostic factor related to protease-activated
receptor 2 expression |
Articolo in rivista |
Vai |
| 2013 |
BIBF 1120/nintedanib: a new triple angiokinase inhibitor-directed therapy in patients with non-small cell lung cancer |
Articolo in rivista |
Vai |
| 2013 |
S9-Fibronectin, EGF-R, HB-EGF:biomarkers of urothelial damage during intravesical adjuvant therapy? |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2013 |
Hypoxia and Human Genome Stability: Downregulation of BRCA2 Expression in Breast Cancer Cell Lines |
Articolo in rivista |
Vai |
| 2013 |
Effects of PPARγ agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells. |
Articolo in rivista |
Vai |
| 2013 |
TNF-alpha gene promoter polymorphisms and risk of venous thromboembolism in gastrointestinal cancer patients undergoing chemotherapy |
Articolo in rivista |
Vai |
| 2013 |
BIOMARKERS OF UROTHELIAL DAMAGE IN PATIENTS TREATED BY ADJUVANT INTRAVESICAL THERAPY |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2013 |
The Risk of Toxicities from Trastuzumab, Alone or in Combination, in an Elderly Breast Cancer Population |
Articolo in rivista |
Vai |
| 2013 |
Co-expression of CD133+/CD44+in human colon cancer and liver metastasis |
Articolo in rivista |
Vai |
| 2013 |
Leptin plasma levels in patients undergoing prostate biopsy. a preliminary study in 50 patients |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2013 |
Correlation between leptin plasmatic levels in non-obese patients and detection rate at prostate biopsy”- Poster P147 |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2013 |
HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions |
Articolo in rivista |
Vai |
| 2013 |
SULT1A1gene deletion inBRCA2-associated male breast cancer: a link between genes and environmental exposures? |
Articolo in rivista |
Vai |
| 2013 |
Dilemma in metastatic colorectal cancer: VEGF versus EGRF targeting |
Articolo in rivista |
Vai |
| 2013 |
Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patients |
Articolo in rivista |
Vai |
| 2013 |
Role of curcumin in idiopathic pulmonary arterial hypertension treatment: A new therapeutic possibility |
Articolo in rivista |
Vai |
| 2013 |
MicroRNAs in Colorectal Cancer Drug Resistance: Shooters become Targets |
Articolo in rivista |
Vai |
| 2013 |
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting |
Articolo in rivista |
Vai |
| 2012 |
PML expression in soft tissue sarcoma: Prognostic and predictive value in
alkylating agents/antracycline-based first line therapy. |
Articolo in rivista |
Vai |
| 2012 |
A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients |
Articolo in rivista |
Vai |
| 2012 |
Gene signatures in CRC and liver metastasis |
Capitolo o Saggio |
Vai |
| 2012 |
Primary epithelial ovarian neoplasms: New conceptsconcerning origin, pathogenesis and classification based on morphology, immunomarkers, molecular features, and gene expression studies |
Capitolo o Saggio |
Vai |
| 2012 |
Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in Italy |
Articolo in rivista |
Vai |
| 2012 |
Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy |
Articolo in rivista |
Vai |
| 2012 |
Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells |
Articolo in rivista |
Vai |
| 2012 |
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance? |
Articolo in rivista |
Vai |
| 2012 |
What are the Cancer Risks in BRCA Carriers Apart from Those Regarding the Breast and the Ovary? |
Articolo in rivista |
Vai |
| 2012 |
Diagnostic, Prognostic and Therapeutic Value of Gene Signatures |
Curatela |
Vai |
| 2012 |
How Much of Familial Breast Cancer Risk is Currently Explained by the Known Genes? |
Articolo in rivista |
Vai |
| 2012 |
The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies |
Articolo in rivista |
Vai |
| 2012 |
MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness? |
Articolo in rivista |
Vai |
| 2012 |
Janus kinase (JAK) 2 V617F mutation as the cause of primary thrombocythemia in acromegaly with severe visceromegaly and divergence between growth hormone and insulin-like growth factor-1 concentrations during the follow-up: causal or casual association? |
Articolo in rivista |
Vai |
| 2012 |
Breast cancer genome-wide association studies: there is strength in numbers |
Articolo in rivista |
Vai |
| 2012 |
Serum levels of angiogenetic cancer biomarkers in men undergoing prostate biopsy. Preliminary data |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2012 |
Role of CML exosomes in the crosstalk between chronic myelogenous leukemia and bone-marrow derived exosomes |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2012 |
The Insulin Receptor Substrate 1 (Irs1) in Intestinal Epithelial Differentiation and in Colorectal Cancer |
Articolo in rivista |
Vai |
| 2012 |
PML as a potential predictive factor of oxaliplatin/fluoropyrimidine-based first line chemotherapy efficacy in colorectal cancer patients |
Articolo in rivista |
Vai |
| 2012 |
role of CML exosomes in the crosstalk between chronic myelogenous leukaemia and bone marrow-derived cells |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2011 |
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases |
Articolo in rivista |
Vai |
| 2011 |
Predicting efficacy and toxicity in the era of targeted therapy: focus on anti-EGFR and anti-VEGF molecules |
Articolo in rivista |
Vai |
| 2011 |
Cigarette smoking habit does not reduce the benefit from first line trastuzumab-based treatment in advanced breast cancer patients |
Articolo in rivista |
Vai |
| 2011 |
Protection from work stress and burnout in Italian oncologists |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2011 |
Biomarkers and efficacy: Are we nearly there yet? |
Articolo in rivista |
Vai |
| 2011 |
CTCF and BORIS Regulate Rb2/p130 Gene Transcription: A Novel Mechanism and a New Paradigm for Understanding the Biology of Lung Cancer |
Articolo in rivista |
Vai |
| 2011 |
Pharmacokinetic and metabolism determinants of fluoropyrimidines and oxaliplatin activity in treatment of colorectal patients |
Articolo in rivista |
Vai |
| 2011 |
Receptor Activator of NF-kB (RANK) Expression in Primary Tumors Associates with Bone Metastasis Occurrence in Breast Cancer Patients |
Articolo in rivista |
Vai |
| 2011 |
Monoclonal antibodies and antibody fragments: state of the art and future perspectives in the treatment of non-haematological tumors |
Articolo in rivista |
Vai |
| 2011 |
EGFR genomic alterations in cancer: prognostic and predictive values |
Articolo in rivista |
Vai |
| 2011 |
Janus kinase (JAK) 2 V617F mutation as the cause of primary thrombocythemia, severe visceromegaly and divergence between growth hormone and insulin-like growth factor-1 concentrations in acromegaly due to a therapeutically resistant pituitary GH-secreting macroadenoma |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2011 |
Human equilibrative nucleoside transporter 1 (hENT1) levels predict response to gemcitabine in patients with biliary tract cancer (BTC) |
Articolo in rivista |
Vai |
| 2010 |
New molecular targets in bone metastases |
Articolo in rivista |
Vai |
| 2010 |
WELL-BEING, SOURCES OF STRESS AND COPING STRATEGIES IN A SAMPLE OF ONCOLOGISTS |
Articolo in rivista |
Vai |
| 2010 |
The long and winding road to useful predictive factors for anti-egfr therapy in metastatic colorectal carcinoma: The KRAS/BRAF pathway |
Articolo in rivista |
Vai |
| 2010 |
EFFECT OF miR-21, miR-182 AND let-7i ON TSP-1 EXPRESSION IN COLON CANCER CELL LINE |
Abstract in rivista |
Vai |
| 2010 |
Cetuximab plus FOLFOX-4 in untreated patients with advanced colorectal cancer: A gruppo oncologico dell'Italia meridionale multicenter phase II study |
Articolo in rivista |
Vai |
| 2010 |
Cetuximab in small bowel adenocarcinoma: A new friend |
Articolo in rivista |
Vai |
| 2010 |
The dark side of the moon: The PI3K/PTEN/AKT pathway in colorectal carcinoma |
Articolo in rivista |
Vai |
| 2010 |
p53 as the main traffic controller of the cell signaling network |
Articolo in rivista |
Vai |
| 2010 |
Update on capecitabine alone and in combination regimens in colorectal cancer patients |
Articolo in rivista |
Vai |
| 2010 |
Bortezomib: a new pro-apoptotic agent in cancer treatment. |
Articolo in rivista |
Vai |
| 2010 |
Triplet schedule of weekly 5-Fluorouracil and alternating irinotecan or oxaliplatin in advanced colorectal cancer: A dose-finding and phase II study |
Articolo in rivista |
Vai |
| 2010 |
Drug-Related Cardiotoxicity for the Treatment of Haematological Malignancies in Elderly. |
Articolo in rivista |
Vai |
| 2010 |
PML down-regulation in soft tissue sarcomas. |
Articolo in rivista |
Vai |
| 2010 |
VUS variants in BRCA genes of hereditary breast/ovarian cancer |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2010 |
miR-20b Modulates VEGF
Expression by Targeting HIF-1a
and STAT3 in MCF-7 Breast
Cancer Cells |
Articolo in rivista |
Vai |
| 2010 |
Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer |
Articolo in rivista |
Vai |
| 2010 |
PML expression in soft tissue sarcoma: prognostic value in alkilating agents/anthracyclin based first line therapy |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2010 |
THE ROLE OF PSYCHOLOGICAL ASPECTS IN ONCOGENETIC COUNSELLING |
Articolo in rivista |
Vai |
| 2010 |
Early Skin Toxicity as a Predictive Factor for Tumor Control in Hepatocellular Carcinoma Patients Treated with Sorafenib. |
Articolo in rivista |
Vai |
| 2010 |
Anti-endothelin drugs in solid tumors |
Articolo in rivista |
Vai |
| 2010 |
R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair |
Articolo in rivista |
Vai |
| 2010 |
Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma |
Articolo in rivista |
Vai |
| 2010 |
PML down-regulation in soft tissue sarcomas |
Articolo in rivista |
Vai |
| 2010 |
The Clinical Significance of Unknown Sequence Variants in BRCA Genes |
Articolo in rivista |
Vai |
| 2010 |
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy? |
Articolo in rivista |
Vai |
| 2010 |
HER2-positive male breast cancer: An update |
Articolo in rivista |
Vai |
| 2009 |
ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy. |
Articolo in rivista |
Vai |
| 2009 |
Expression of angiogenic regulators, VEGF and leptin, is regulated by the
EGF/PI3K/STAT3 pathway in colorectal cancer cells. |
Articolo in rivista |
Vai |
| 2009 |
Analysis of germline gene copy number variants of patients with sporadic pancreatic adenocarcinoma reveals specific variations |
Abstract in rivista |
Vai |
| 2009 |
Promyelocytic leukemia (PML) gene expression is a prognostic factor in ampullary cancer patients |
Articolo in rivista |
Vai |
| 2009 |
Expression of angiogenic regulators. VEGF and leptin, is regulated by the EGF/P13K/STAT3 pathway in colorectal cancer cells |
Articolo in rivista |
Vai |
| 2009 |
Hereditary ovarian cancer |
Articolo in rivista |
Vai |
| 2009 |
Male breast cancer. |
Articolo in rivista |
Vai |
| 2009 |
Gemcitabine-based doublets versus single-agent therapy for elderly patients with advanced nonsmall cell lung cancer: a Literature-based Meta-analysis. |
Articolo in rivista |
Vai |
| 2009 |
Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation? |
Articolo in rivista |
Vai |
| 2009 |
Early stage nasal vestibule tumors: safety and efficacy of HDR brachyterapy in elderly patients |
Abstract in rivista |
Vai |
| 2009 |
The impact of the patient's Adjustment to breast cancer of the burden and distress of the caregiver. |
Abstract in rivista |
Vai |
| 2009 |
Assessment of "grading" with Ki-67 and c-kit immunohistochemical expressions may be a helpful tool in management of patients with flat epithelial atypia (FEA) and columnar cell lesions (CCLs) on core breast biopsy. |
Articolo in rivista |
Vai |
| 2009 |
the proximal leptin gene promoter is regulated by ppar gamma agonist in MCF-7 and MDA-MB-231 breast cancer cells |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2009 |
Benessere, fonti di stress e strategie di coping in un campione di medici oncologi |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2009 |
Functional analysis of the -2548G/A leptin gene polymorphism
in breast cancer cells. |
Articolo in rivista |
Vai |
| 2009 |
Downregulated expression of Cdc25A gene in MCF-7 breast cancer cell |
Abstract in rivista |
Vai |
| 2009 |
Quantitative fluorescence determination of long-fragment DNA in stool as a marker for the early detection of colorectal cancer |
Articolo in rivista |
Vai |
| 2009 |
I tumori della mammella e/o dell’ovaio di tipo eredofamiliare:
strategie di prevenzione nelle donne ad alto
rischio |
Capitolo o Saggio |
Vai |
| 2009 |
EGF Induces STAT3-Dependent VEGF Expression in HT-29 colon cancer cells |
Abstract in rivista |
Vai |
| 2009 |
Comparison between palonosetron(P) and aprepitant (A) versus palonosetron alone for antiemetic prophylaxis in advanced soft tissue sarcoma (STS)patients treated with epirubicin and ifosfamide. |
Abstract in rivista |
Vai |
| 2009 |
A literature-based meta-analysis of the comparison between Gemcitabine-based combination and monochemotherapy for the treatment of advanced non-small cell lung cancer in elderly patients |
Abstract in rivista |
Vai |
| 2009 |
Gefitinib in lung cancer therapy: Clinical results, predictive markers of response and future perspectives |
Articolo in rivista |
Vai |
| 2009 |
Low dose splenic irradiation in myelofibrosis: outcomes and toxicity of three radiation schedule |
Abstract in rivista |
Vai |
| 2009 |
BRCA1 and BRCA2 germline mutations in sicilian breast and/or ovarian cancer families and their association with familial profiles |
Abstract in rivista |
Vai |
| 2009 |
Antiemetic prophylaxis containing Palonosetron (P) alone or in combination with Aprepitant (A) in the treatment of advanced soft tissue sarcoma (STS) patients with epirubicin and ifosfamide |
Abstract in rivista |
Vai |
| 2009 |
Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial. |
Articolo in rivista |
Vai |
| 2009 |
KRAS mutations and sensitivity to anti-EGFR monoclonal antibodies in metastatic colorectal carcinoma: an open issue. |
Articolo in rivista |
Vai |
| 2009 |
BRCA1 and BRCA2 variants of uncertain clinical significance and their implications for genetic counseling |
Abstract in rivista |
Vai |
| 2008 |
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome |
Articolo in rivista |
Vai |
| 2008 |
TRANSKETOLASE-LIKE 1 EXPRESSION IN PAPILLARY THYROID CARCINOMAS SMALLER THAN 1.5 CM |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2008 |
The Use of Lenograstim in the prevention of chemotherapy induced neutropenia in patiets with soft tissue sarcoma (STS) |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2008 |
Insulin-dependent leptin expression in breast cancer cells. |
Articolo in rivista |
Vai |
| 2008 |
Use of saliva as a biological medium in non invasive screening for oral cancer |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2008 |
La consulenza genetica in oncologia: implicazioni biomolecolari e cliniche. |
Articolo in rivista |
Vai |
| 2008 |
Pegylated liposomal doxorubicin (PLD) and weekly paclitaxel (P) as second line chemotherapy in metastatic bladder cancer. |
Abstract in rivista |
Vai |
| 2008 |
Gists eredo familiari e pediatrici: aspetti biomolecolari e clinici. |
Capitolo o Saggio |
Vai |
| 2008 |
Increased expression of transketolase-like-1 in papillary thyroid carcinomas smaller than 1.5 cm in diameter is associated with lymph-node metastases. |
Articolo in rivista |
Vai |
| 2008 |
The risk of developing a second, different, cancer among 14 560 survivors of malignant cutaneous melanoma: a study by AIRTUM (the Italian Network of Cancer Registries). |
Articolo in rivista |
Vai |
| 2008 |
Could starvation minimize chemotherapy-induced toxicities? |
Articolo in rivista |
Vai |
| 2008 |
HPV-INFECTION IN ORAL SQUAMOUS CELL
CARCINOMA IN RELATION WITH S-PHASE KINASE-INTERACTING PROTEIN 2 AND P27KIP1 PROTEIN EXPRESSION |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2008 |
HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies:a meta-analysis(1988-2007) |
Articolo in rivista |
Vai |
| 2008 |
BRCA1/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases. |
Articolo in rivista |
Vai |
| 2008 |
High concordance of KRAS status between primary colorectal tumors and related metastatic sites: implications for clinical practice. |
Articolo in rivista |
Vai |
| 2008 |
Solitary necrotic nodule of the liver: different pathological findings express a different histogenesis |
Articolo in rivista |
Vai |
| 2007 |
Role of S128R polymorphism of E-selectin in colon metastasis formation |
Articolo in rivista |
Vai |
| 2007 |
Bisphosphonate-related osteonecrosis of the jaw (BRONJ): run dental management
designs and issues in diagnosis. |
Articolo in rivista |
Vai |
| 2007 |
BRCA1 genetic testing in 106 breast and ovarian cancer families from southern Italy (Sicily): a mutation analyses. |
Articolo in rivista |
Vai |
| 2007 |
Safety and activity of trastuzumab-containing therapies for the treatment of metastatic breast cancer: our long-term clinical experience (GOIM study). |
Abstract in rivista |
Vai |
| 2007 |
Molecular analysis of TP53, Ki-Ras and P16 methylation status in tissue and plasma of subjects affected by gastrointestinal cancer (GIC) |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2007 |
High prevalence of BRCA1 deletions in BRCAPRO-positive patients with high carrier
probability. |
Articolo in rivista |
Vai |
| 2007 |
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan |
Articolo in rivista |
Vai |
| 2007 |
The estrogen receptor alpha:insulin receptor substrate 1 complex in breast cancer: structure-function relationships |
Articolo in rivista |
Vai |
| 2007 |
Genotype analysis of colorectal carcinomas through laser pressare catapulting (LPC) |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2007 |
Mechanism of leptin expression in breast cancer cells: role of hypoxia-inducible factor-1alpha. |
Articolo in rivista |
Vai |
| 2007 |
BRCA 1/2 VARIANTS OF UNCERTAIN CLINICAL SIGNIFICANCE IN PATIENTS WITH FAMILIAL AND HEREDITARY BREAST/OVARIAN CANCER |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2007 |
BRCA 1/2 GENES MUTATIONAL SCREENING IN SICILIAN BREAST AND/OR OVARIAN CANCER FAMILIES |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2007 |
Analysis of Ki-Ras mutations in stage I rectal carcinomas and respective regional lymph nodes. |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2007 |
Reelin expression in human prostate cancer: a marker of tumor aggressiveness based on correlation with grade. |
Articolo in rivista |
Vai |
| 2007 |
The role of Aurora-A inhibitors in cancer therapy. |
Articolo in rivista |
Vai |
| 2007 |
Gastrointestinal stromal tumors (GISTs): focus on histopathological diagnosis and
biomolecular features |
Articolo in rivista |
Vai |
| 2007 |
Aberrant methylation within RUNX3 CpG island associated with the nuclear and
mitochondrial microsatellite instability in sporadic gastric cancers. Results of
a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. |
Articolo in rivista |
Vai |
| 2007 |
Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. |
Articolo in rivista |
Vai |
| 2007 |
Emotional expression and coping style in female breast cancer. |
Articolo in rivista |
Vai |
| 2007 |
GENOTYPE ANALYSIS OF COLORECTAL CARCINOMAS THROUGH LASER PRESSURE CATAPULTING (LPC) |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2007 |
Aurora-A overexpression as an early marker of reflux-related columnar mucosa and Barrett's oesophagus. |
Articolo in rivista |
Vai |
| 2007 |
Colon Cancer Stem Cells Dictate Tumor Growth and Resist Cell Death by Production of Interleukin-4 |
Articolo in rivista |
Vai |
| 2007 |
Expression of the obesity hormone leptin and its receptor correlates with
hypoxia-inducible factor-1alpha in human colorectal cancer. |
Articolo in rivista |
Vai |
| 2007 |
Patterns of genomic instability in gastric cancer: clinical implications and perspectives. |
Articolo in rivista |
Vai |
| 2007 |
Alexithymia and coping style in women going to visit in a breast cancer center. |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2007 |
Carcinoma ereditario dell'ovaio (Ereditary Ovarian Cancer) |
Capitolo o Saggio |
Vai |
| 2007 |
TP53, Ki-Ras and P16INK4A gene molecular analysis in salivary gland tumors. |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2007 |
BRAFV600E Mutation and p27kip1 Expression in
Papillary Carcinomas of the Thyroid ≤1 cm and
Their Paired Lymph Node Metastases |
Articolo in rivista |
Vai |
| 2007 |
Analysis of extended genomic rearrangements in oncological research. |
Articolo in rivista |
Vai |
| 2007 |
A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer. |
Articolo in rivista |
Vai |
| 2007 |
Founder mutations in BRCA1 and BRCA2 genes |
Articolo in rivista |
Vai |
| 2007 |
TP53, H-K-RAS, P16INK4A GENE MOLECULAR ANALYSIS IN SALIVARY GLAND TUMORS |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2007 |
Alexithymia and copyng style in women going to visit in a breast cancer center |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2007 |
Targeting apoptosis in solid tumors: the role of bortezomib from preclinical to clinical evidence. |
Articolo in rivista |
Vai |
| 2007 |
Analysis of TP53, Ki-Ras and P16INK4A promoter methylation as potential prognostic factors in patients with colorectal cancer |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2007 |
4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily). |
Articolo in rivista |
Vai |
| 2007 |
Expression level of the mammaglobin (MGB1) gene in BC:possibile index of BC progression |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2007 |
Aplotype analysis in four sicilian families with 5083del19bp-BRCA1. |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2006 |
Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers |
Articolo in rivista |
Vai |
| 2006 |
Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study |
Articolo in rivista |
Vai |
| 2006 |
Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. |
Articolo in rivista |
Vai |
| 2006 |
Novel P53 mutations detected by FAMA in colorectal cancers |
Articolo in rivista |
Vai |
| 2006 |
A study of a new germline mutation in BRCA1 gene in two Sicilian families: a founder mutation? |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2006 |
Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line
chemotherapy for elderly patients with advanced gastric cancer: results of a
phase II trial. |
Articolo in rivista |
Vai |
| 2006 |
Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients. |
Articolo in rivista |
Vai |
| 2006 |
A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma |
Articolo in rivista |
Vai |
| 2006 |
Ductal lavage: a way of carefully tracing the breast-secreting duct |
Articolo in rivista |
Vai |
| 2006 |
P16 ink4A, p53 alterations and S phase fraction are predictive of clinical outcome in laryngeal squamous cell carcinoma. |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2006 |
TP53, h-k-ras,p16ink4a gene molecular analysis in salivary gland tumors |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2006 |
Insulin-like growth factor 1 differentially regulates estrogen
receptor-dependent transcription at estrogen response element and AP-1 sites in
breast cancer cells. |
Articolo in rivista |
Vai |
| 2006 |
TP53 and p16INK4A, but not H-KI-Ras, are involved in tumorigenesis and
progression of pleomorphic adenomas. |
Articolo in rivista |
Vai |
| 2006 |
TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma |
Articolo in rivista |
Vai |
| 2006 |
TP53 mutations and microsatellite instability are prognostic factors in gastric cancer? |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2006 |
Y179C, F486L and N550H are BRCA1 variants that may be associated with breast cancer in a Sicilian family: results of a 5-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study |
Articolo in rivista |
Vai |
| 2006 |
Q356R and S1512I are BRCA1 variants that may be associated with breast cancer in a Sicilian family. |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2006 |
BRCA1 missense variants of uncertain clinical significance in unaffected and breast/ovarian cancer of the Sicilian population. |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2006 |
Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. |
Articolo in rivista |
Vai |
| 2006 |
Detection of BRAFV600 mutation in papillary thyroid carcinoma using real time allele-specific amplification on fine needle aspiration biopsy specimens |
Articolo in rivista |
Vai |
| 2006 |
Role of S128R polymorphism of E-Selectin in colon metastasis formation. |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2006 |
Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli |
Articolo in rivista |
Vai |
| 2006 |
A new germline mutation in BRCA1 gene in a sicilian family with ovarian cancer. |
Articolo in rivista |
Vai |
| 2006 |
P16, p53 altertaions and S phase fraction are predictive of clinical outcome in Laringeal squamous cell carcinoma. |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2006 |
Localisation immunohistochemique du factuer natriuretique atriale du tissu muqueux mur du Cordon Ombelical humain après naissance et dans la Pulpe Dentaire. |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2006 |
Detection of BRAFv600E mutation in papillary thyroid carcinoma using real time allele-specific amplification on fine needle aspiration biopsy specimens. |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2006 |
Patterns of K-ras mutation in colorectal carcinomas from Iran and Italy (a
Gruppo Oncologico dell'Italia Meridionale study): influence of microsatellite
instability status and country of origin. |
Articolo in rivista |
Vai |
| 2006 |
TP 53, H-K-Ras, P16INK4A gene molecular analysis in salivary gland tumors. |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2006 |
A missense mutation associated to early onset breast cancer in a sicilian woman. |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2006 |
BRCA1 germline mutations in Sicilian breast and/or ovarian cancer families and their implications for genetic counselling. |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2006 |
Apoptosis: a relevant tool for anticancer therapy. |
Articolo in rivista |
Vai |
| 2006 |
Gastric adenomas: relationship between clinicopathological findings, Helicobacter pylori infection, APC mutations and COX-2 expression. |
Articolo in rivista |
Vai |
| 2006 |
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study. |
Articolo in rivista |
Vai |
| 2006 |
A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC) |
Articolo in rivista |
Vai |
| 2005 |
Pharmacogenomics in colorectal carcinomas: Future perspectives in personalized therapy |
Articolo in rivista |
Vai |
| 2005 |
The prognostic role of TP53 mutations in advanced laryngeal squamous cell carcinoma (LSCC). |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2005 |
Oral temozolomide in heavily pre-treated brain metastases from non-small cell lung cancer: phase II study |
Articolo in rivista |
Vai |
| 2005 |
Prognostic and predictive factors in colorectal cancer: Kirsten Ras in CRC
(RASCAL) and TP53CRC collaborative studies. |
Articolo in rivista |
Vai |
| 2005 |
A.Mutational analysis of BRCA1 in sicilian patients at risk for inherited of reference center for the biomolecular characterizaztion of neoplasm and genetic screening of hereditary tumors |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2005 |
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical
outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo
Oncologico dell'Italia Meridionale (GOIM) prospective study. |
Articolo in rivista |
Vai |
| 2005 |
Paclitaxel, carboplatin and gemcitabine combination as induction chemotherapy
for stage IIIA N2 bulky non-small cell lung cancer |
Articolo in rivista |
Vai |
| 2005 |
TP53 mutations and S-Phase fraction are independent prognostic indicators in locally advanced laryngeal squamous cell carcinoma |
Altro |
Vai |
| 2005 |
Il polimorfismo S128R dell’E-Selectina: analisi genotipica e caratterizzazione funzionale nell’interazione cellule tumorale-endotelio. |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2005 |
Role of S128R polymorphism of E-Selectin: in colon metastasis formation |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2005 |
The Use of Gemcitabine in heavily pretreted breast cancer patients |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2005 |
Farmacogenomica nei carcinomi colorettali: prospettive nella terapia personalizzata |
Capitolo o Saggio |
Vai |
| 2005 |
TP53 mutations are not prognostic indipendent indicators in bladder cancer |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2005 |
The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers |
Articolo in rivista |
Vai |
| 2005 |
Mutational analysis of BRCA1 gene in sicilian patients at risk for inherited breast and/or ovarian cancer: experience of reference centre for the biomolecular characterization of neoplasms and genetic screening of hereditary tumors. |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2005 |
Analysis of Ki-ras mutations in stage I rectal carcinomas and respective regional lymphonodes |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2005 |
Laser Pressure Catapulting (LPC): Optimization LPC-System and Genotyping of Colorectal Carcinomas |
Articolo in rivista |
Vai |
| 2005 |
Mutational analysis of BRCA1 gene in sicilian patient at risk for inherited breast and/or ovarian cancer: experience of reference center the biomolecular characterization of neoplasm and genetic screening of hereditary tumors. |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2005 |
TP53 mutations are not prognostic independent indicators in bladder cancer. |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2005 |
The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment |
Articolo in rivista |
Vai |
| 2005 |
Detection of free-circulating tumor DNA in plasma of patients with gastrointestinal cancer. |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2005 |
Le basi scientifiche della cancerogenesi: “up-date” |
Capitolo o Saggio |
Vai |
| 2005 |
TP53 Mutation in exon 5 and S-Phase Fraction but not Mutations in Ras gene family and DNA-ploidy are Indipendent prognostic indicators in Laryngeal Squamous Cell Carcinoma |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2004 |
RUOLO DI P53 E DEI GENI K-RAS EDH-RAS NELLA TUMORIGENESI DELLE GHIANDOLE SALIVARI |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2004 |
A phase II study of capecitabine oxaliplatin chemotherapy in metastatic breast cancer patients pretreated with anthracyclines and taxanes |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2004 |
Detection and clinical relevance of free-circulating tumor DNA in blood of patients with colorectal cancer |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2004 |
DNA-aneuploidy and high SPF and specific p53 mutations are independent prognostic factors in colorectal cancer (CRC). |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2004 |
Weekly Paclitaxel (T) and pegylated liposomal Doxorubicin (PLD) as first line treatment in metastatic breast cancer (MBC) patients.VII CONGRESSO NAZIONALE G.O.I.M. ROMA 23-25 Giugno 2004 |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2004 |
DNA-Aneuploidy, High SPF and Specific P53 Mutations are Indipendent Prognostic Factors in Colorectal Cancer (CRC) |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2004 |
RUOLO DI P53 E DEI GENI K-RAS ED H-RAS NELLA TUMORIGENESI DEI CARCINOMI DELLE GHIANDOLE SALIVARI |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2004 |
Pegylated Liposomal Doxorubicin and weekly paclitaxel as first line treatment in metastatic breast cancer |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2004 |
Role of K-RAS and P53 Gene in Salivary Glands Tumorigenesis |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2004 |
Fattori Predittivi di Risposta ai Citostatici nei Tumori del Tratto Gastrointestinale |
Capitolo o Saggio |
Vai |
| 2004 |
DNA aneuploidy, high SPF and specific p53 mutations are independent prognostic factors in colorectale cancer (CRC) |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2004 |
Heterogeneity within and between primary colorectal carcinomas and matched metastases as revealed by analysis of Ki-ras and p53 mutations |
Articolo in rivista |
Vai |
| 2004 |
Consultorio Genetico |
Monografia |
Vai |
| 2004 |
TP53 in gastric cancer: mutations in the l3 loop and LSH motif DNA-binding domains of TP53 predict poor outcome |
Articolo in rivista |
Vai |
| 2004 |
Detection and clinical relevance of free-circulating tumor DNA in blood of patients with colorectal cancer. Proceeding of ICACT Fifteenth International Congress on Anticancer Treatment February 9th 12th 2004, Paris accepted for oral presentation |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2003 |
STAT Proteins: From Normal Control of Cellular Events to Tumorigenesis |
Articolo in rivista |
Vai |
| 2002 |
p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: A prospective study with a five-year follow-up |
Articolo in rivista |
Vai |
| 2002 |
Havep53 gene mutations and protein expression a different biological significance in colorectal cancer? |
Articolo in rivista |
Vai |
| 2002 |
Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype |
Articolo in rivista |
Vai |
| 2002 |
Ras family genes: An interesting link between cell cycle and cancer |
Articolo in rivista |
Vai |
| 2002 |
DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study |
Articolo in rivista |
Vai |
| 2002 |
Prognostic significance of p16INK4a alterations and 9p21 loss of heterozigosity in locally advanced laryngeal squamous cell carcinoma |
Articolo in rivista |
Vai |
| 2001 |
DNA aneuploidy and high proliferative activity but not K-ras-2 mutations as independent predictors of clinical outcome in operable gastric carcinoma: Results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study |
Articolo in rivista |
Vai |
| 2001 |
Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study |
Articolo in rivista |
Vai |
| 2000 |
Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma |
Articolo in rivista |
Vai |
| 2000 |
Hereditary common cancers: Molecular and clinical genetics |
Articolo in rivista |
Vai |
| 1995 |
Flow cytometric DNA analysis and lysosomal cathepsins b and l in locally advanced laryngeal cancer. Relationship with clinicopathologic parameters and prognostic significance |
Articolo in rivista |
Vai |
